FDA Clears Device to Assist in Earlier Diagnosis of Autism Spectrum Disorder
The FDA has cleared EarliPoint Evaluation for the diagnosis and assessment of autism spectrum disorder in children 16 to 30 months of age.
Sreeni Narayanan Yale University Emory University School Of Medicine Drug Administration Earlipoint Evaluation Emory University School
Source: clinicaladvisor.com